KISS1R and metabolic dysfunction-associated steatotic liver disease: Thus, based on the accumulating evidence demonstrating a protective effect of KISS1R signaling in the development of MASLD, we hypothesize that KISS1R signaling directly decreases DNL and the formation of new intrahepatic triglycerides.